(Q37008887)

17 August 2017

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers (English)

1 reference

17 August 2017

0 references

0 references

0 references

0 references

37

1 reference

17 August 2017

25

Sanna-Kaisa Herukka

0 references

Hilkka Soininen

60

Hilkka Soininen

0 references

José Luis Molinuevo

José Luis Molinuevo

47

0 references

Alessandro Stefani

Alessandro Stefani

59

0 references

Marinus Blankenstein

Marinus A Blankenstein

8

0 references

Daniela Galimberti

Daniela Galimberti

20

0 references

Elio Scarpini

Elio Scarpini

58

0 references

Giovanni B. Frisoni

Giovanni B Frisoni

18

0 references

Henrik Zetterberg

77

Henrik Zetterberg

1 reference

17 August 2017

21

Harald Hampel

1 reference

17 August 2017

78

Kaj Blennow

1 reference

17 August 2017

68

John Q Trojanowski

1 reference

17 August 2017

26

David M Holtzman

1 reference

17 August 2017

9

Maria C Carrillo

1 reference

17 August 2017

67

Charlotte Teunissen

1 reference

17 August 2017

16

Anne M Fagan

1 reference

17 August 2017

43

Colin Masters

1 reference

17 August 2017

54

Ronald C Petersen

1 reference

17 August 2017

28

Bradley T Hyman

1 reference

17 August 2017

1

Niklas Mattsson

1 reference

17 August 2017

30

Mathias Jucker

1 reference

17 August 2017

2

Ulf Andreasson

1 reference

17 August 2017

62

Leslie M Shaw

1 reference

17 August 2017

72

Hugo Vanderstichele

1 reference

17 August 2017

53

Lucilla Parnetti

1 reference

17 August 2017

11

Els Coart

1 reference

17 August 2017

73

Laszlo Vecsei

1 reference

17 August 2017

27

Christian Humpel

1 reference

17 August 2017

69

Hayrettin Tumani

1 reference

17 August 2017

48

Thomas J Montine

1 reference

17 August 2017

41

Qiao-Xin Li

1 reference

17 August 2017

19

Douglas Galasko

1 reference

17 August 2017

23

Michael T Heneka

1 reference

17 August 2017

74

Marcel M Verbeek

1 reference

Luisella Bocchio Chiavetto

17 August 2017

7

Luisella Bocchio-Chiavetto

1 reference

17 August 2017

10

Sonia Chalbot

1 reference

17 August 2017

29

Khalid Iqbal

1 reference

17 August 2017

45

Marc Mercken

1 reference

17 August 2017

46

Abhay Moghekar

1 reference

17 August 2017

35

Peter Klivenyi

1 reference

17 August 2017

40

Piotr Lewczuk

1 reference

17 August 2017

Albert Llado Plarrumani

39

Albert Lladó

1 reference

17 August 2017

33

Elisabeth Kapaki

1 reference

17 August 2017

3

Staffan Persson

1 reference

17 August 2017

13

Neal Cutler

1 reference

17 August 2017

31

Stephan A Kaeser

1 reference

17 August 2017

57

Robert A Rissman

1 reference

17 August 2017

12

Davide Chiasserini

1 reference

17 August 2017

17

Orestes Forlenza

1 reference

17 August 2017

34

Daniel Kidd

1 reference

17 August 2017

63

Anders Skinningsrud

1 reference

17 August 2017

70

Robert M Umek

1 reference

17 August 2017

71

Bianca Van Broeck

1 reference

17 August 2017

52

George P Paraskevas

1 reference

17 August 2017

Hiroyuki Arai

4

1 reference

17 August 2017

Sat Dev Batish

5

1 reference

17 August 2017

Sergio Bernardini

6

1 reference

17 August 2017

Gunilla Dahlfors

14

1 reference

17 August 2017

Stefan Duller

15

1 reference

17 August 2017

Aase Handberg

22

1 reference

17 August 2017

Adrianna Z Herskovits

24

1 reference

17 August 2017

Elmar Kaiser

32

1 reference

17 August 2017

Cindy S Knudsen

36

1 reference

17 August 2017

James Lui

38

1 reference

17 August 2017

Ralph Martins

42

1 reference

17 August 2017

John McAuliffe

44

1 reference

17 August 2017

William Nowatzke

49

1 reference

17 August 2017

Richard O'Brien

50

1 reference

17 August 2017

Markus Otto

51

1 reference

17 August 2017

David Prvulovic

55

1 reference

17 August 2017

Herman P M de Reus

56

1 reference

17 August 2017

Johannes Schröder

61

1 reference

17 August 2017

Brith Skrogstad

64

1 reference

17 August 2017

Annette Spreer

65

1 reference

17 August 2017

Leda Talib

66

1 reference

17 August 2017

Manfred Windisch

75

1 reference

17 August 2017

Jing Zhang

76

1 reference

17 August 2017

1 July 2011

1 reference

17 August 2017

Alzheimer's and Dementia

1 reference

17 August 2017

7

1 reference

17 August 2017

4

1 reference

17 August 2017

386-395.e6

1 reference

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Reference materials and reference measurement procedures: an overview from a national metrology institute

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Characterization of a new certified reference material for human cardiac troponin I.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

CSF markers for incipient Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

PET imaging of amyloid deposition in patients with mild cognitive impairment.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

International quality control survey of neurochemical dementia diagnostics.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid markers for prediction of Alzheimer's disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710290

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21784349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JALZ.2011.05.2243

1 reference

17 August 2017

1 reference

17 August 2017

1 reference